 |
|
|
|
|
 |
Last Updated: Sep 13, 2008 - 5:00:44 PM |
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
Significant vaccine-enhanced immune response in malignant brain tumour
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal Cancer Research.
Jul 15, 2008 - 1:21:44 AM
|
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
Simultaneous implantation of radioactive seeds and chemotherapy wafers promising in glioblastoma multiforme treatment
In the battle against malignant brain tumors, dual implantation of radioactive seeds and chemotherapy wafers following surgery showed promising results in a study led by specialists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.
Jan 20, 2008 - 9:31:57 AM
|
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
New vaccine to fight glioblastoma multiforme developed
A vaccine to fight an aggressive form of brain tumour has been developed by US scientists, who say it can delay progression of the cancer.
May 2, 2006 - 10:40:00 PM
|
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
Discovery could change the way doctors treat glioblastomas
Researchers at UCLA's Jonsson Cancer have identified key characteristics in certain deadly brain tumors that make them 51 times more likely to respond to a specific class of drugs than tumors in which the molecular signature is absent. The discovery of the telltale molecular signature the expression of a mutant protein and the presence of a tumor suppressor protein called PTEN will allow researchers to identify patients who are likely to respond to the drug treatment before they undergo therapies that are not likely to work, said Dr. Paul Mischel, a UCLA associate professor of pathology and laboratory medicine and a Jonsson Cancer Center researcher.
Nov 11, 2005 - 12:46:00 AM
|
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
Glioblastoma Gene Variations Can Predict Treatment Response
Screening glioblastoma brain tumors for two gene variations can reliably predict which tumors will respond to a specific class of drugs, a new study shows. The findings may lead to improved treatment for this devastating disease. The study was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), and appears in the November 10, 2005, issue of the New England Journal of Medicine. Glioblastomas are the most common malignant brain tumors in adults, and they are notoriously difficult to treat successfully. "The survival with glioblastoma is usually a year on average, and that hasn't improved in a while, so this is a very serious and challenging disease," says Paul Mischel, M.D., of the David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California , Los Angeles (UCLA), who led the study. While drugs are available to help treat glioblastoma, they often have minimal effect, and doctors usually have time to try only one or two treatments before the disease causes severe impairment. Glioblastomas feature many genetic variations that affect their response to different treatments. Researchers are trying to identify these genetic factors and to tease apart how they affect the disease in order to determine which patients are the most likely to benefit from specific drugs.
Nov 11, 2005 - 12:20:00 AM
|
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
P-gp system let JV-1-36 pass into the brain to treat malignant glioblastomas
A compound that kills cancer can sneak past the blood brain barrier, which protects the brain from foreign substances, to do its work in fighting a particularly invasive brain cancer, according to a new Saint Louis University animal study published in the Proceedings of the National Academy of Sciences Online Early Edition the week of Aug. 22.
Aug 23, 2005 - 7:56:00 PM
|
Latest Research
:
Cancer
:
Brain
:
Glioblastoma Multiforme
Combined gene therapy can eliminate glioblastoma multiforme
Despite aggressive treatment, glioblastoma multiforme (GBM) the most common and deadly of brain cancers usually claims the lives of its victims within six to 12 months of diagnosis. Because GBM is so aggressive, the disease has been the target of a number of laboratory and clinical studies investigating the effectiveness of gene therapy to deliver novel therapies to the brain. In laboratory studies, this type of gene therapy has proved almost completely effective. But in clinical trials, it has had limited effectiveness.
Aug 15, 2005 - 5:44:00 PM
|
<< prev
next >>
|
|
|
|
| Health |
Do you know if your blood pressure is high?
|
Incubator care at birth reduces depression risk in adult life
|
Kids safe and secure with grandparents around
|
Shed tears to stay healthy
|
1918 Spanish flu records could hold the key to solving future pandemics
|
Listening to classical music may reduce pregnancy stress
|
Most women don't find sexual problems upsetting: Survey
|
Pneumococcal vaccine could prevent numerous deaths, save costs during a flu pandemic, model predicts
|
Breast milk provides baby molecule to build immunity
|
Vaccinating family members protects newborns from flu
|
| | Healthcare |
India, China revive ties in medicine in memory of Kotnis
|
Myanmar faces 24,000 AIDS deaths for lack of ART drugs
|
Malnutrition downplaying India's economic growth: UN
|
India building five blood banks of world standard: Ramados
|
Plan to Start MBBS Courses in IITs not feasible
|
Mid-day meal: 10 schools face action for irregularities
|
Nearly Half of Primary Care Doctors in US Would Like to Quit
|
I aborted after cops pushed me: Sister of absconding doctor
|
Prioritise sanitation in development process: PM
|
Israeli couple makes news, but Indians reluctant on surrogacy
|
| | Latest Research |
Combining patient photos with imaging improves diagnosis
|
An ace for visually-impaired students in computer science
|
Rivers are carbon processors, not inert pipelines
|
Symptoms of depression associated with increase in abdominal fat
|
Psychiatric disorders common among college-age individuals; few seek treatment
|
Delays in radiation therapy lead to increased breast cancer recurrence
|
U of Minnesota Institute on Race and Poverty reports dismal results for charter schools
|
PA-824 : Promising new drug for TB
|
New screening strategy increases Down's syndrome detection before birth
|
Clear advantage of high efficacy Haemodiafiltration over conventional hemodialysis
|
| | Medical News |
India, China revive ties in medicine in memory of Kotnis
|
Disabled stage mass protest at India Gate
|
Dasmunsi continues to be on life support system
|
Kolkata AIDS care centre project shelved after protests
|
Migration to cities causes blood pressure: study
|
Gulzar writes, Shaan sings for music video on AIDS
|
Assam on alert after bird flu spreads to new areas
|
Trust net of marriage makes women vulnerable to HIV: experts
|
Bhopal gas tragedy: 24 years on, the trauma continues
|
Now, disabled-friendly Agra eases Taj experience
|
| | Special Topics |
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
Spiders which eat together, stay together and multiply
|
Anna Hazare - the keeper of the earth and human conscience
|
Indian American scientist wins top IMO prize
|
Artificial human sperm could make men redundant: experts
|
Will autopsy on Benazir's body become necessary?
|
Murders in 'fit of passion' don't deserve death: Apex court
|
Low literacy equals early death sentence
|
New Insights Into the Nature of Pride as a Social Function
|
|
|
